Related Experiment Video
Updated: Oct 3, 2025

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
Published on: December 15, 2023
Prognostic Factors and Clinical Characteristics of Chronic Hepatitis B with or without Nucleos(t)ide Analogues
Manyu Li1, Tingting Li2, Kejian Li3
1Division I of in vitro Diagnostics for Infectious Diseases, Institute for in vitro Diagnostics Control, National Institutes for Food and Drug Control, Beijing, China myli226@163.com zhouch@nifdc.org.cn.
Objective:
We compared the prognostic factors and clinical characteristics of chronic hepatitis B (CHB) patients who received nucleos(t)ide analogues (NAs) therapy to those who did not.
Method:
A total of 315 CHB patients were enrolled in this study and were divided into NA (n=144) and non-NA (n=171) groups based on their therapy.
Results:
The risk of hepatocellular carcinoma (HCC) development and mortality in the NA group were significantly lower than those in the non-NA group. Smoking, alcohol abuse, AFP, γ-GTP, and HBV DNA levels were significantly correlated with hepatocarcinogenesis. Alcohol abuse, AFP, γ-GTP, HBV DNA levels and NA treatment were associated with mortality in these patients.
Conclusions:
NA therapy reduced the risk of HCC and mortality in CHB patients. Smoking, alcohol abuse, AFP >20 ng/mL, HBV DNA >20,000 IU/mL, and elevated γ-GTP serum concentration were significantly related to poor outcomes.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
10:37Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
Related Concept Videos
Retrovirus Life Cycles
Hepatic Drug Excretion: Influencing Factors